Skip to main content
Clinical Trials/JPRN-jRCT1061220076
JPRN-jRCT1061220076
Recruiting
未知

Investigation of the usefulness of proton pump inhibitor (PPI) + Rikkunshi-to in functional dyspepsia

Yachida Tatsuo0 sites90 target enrollmentDecember 23, 2022

Overview

Phase
未知
Intervention
Not specified
Conditions
Functional Dyspepsia
Sponsor
Yachida Tatsuo
Enrollment
90
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
December 23, 2022
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Yachida Tatsuo

Eligibility Criteria

Inclusion Criteria

  • All of the following are required
  • 1\) At least one symptom of dyspepsia on the mFSSG questionnaire
  • 2\) Helicobacter pylori (HP) negative or after HP eradication
  • 3\) 20 years of age or older
  • 4\) Patients must have one of the following symptoms: postprandial complaint syndrome (lethargy and early satiety after eating) or epigastric pain syndrome (epigastric pain and burning sensation in the epigastrium).

Exclusion Criteria

  • Persons who fall into any of the following categories are excluded
  • 1\) Patients with current HP infection
  • 2\) Patients with organic disease on upper gastrointestinal endoscopy
  • 3\) Patients who have already started medical treatment for the same symptoms
  • 4\) Patients taking NSAIDs (non\-steroidal anti\-inflammatory drugs)
  • 5\) Patients with a history of allergy to the drugs to be used
  • 6\) Patients deemed inappropriate by the investigator

Outcomes

Primary Outcomes

Not specified

Similar Trials

Recruiting
Phase 3
Comparison of the effect of baclofen and proton pump inhibitors in patients with gastroesophageal reflux diseasegastroesophageal reflux disease.Gastro-esophageal reflux disease
IRCT20210308050634N1Islamic Azad University60
Completed
Not Applicable
Study of the improvement effect of proton pump inhibitors on symptoms in patients with reflux esophagitis (RE): a randomized double-blind comparative study of esomeprazole 20mg vs. rabeprazole 10mg
JPRN-UMIN000010450Juntendo University School of Medicine, Department of Gastroenterology and Hepatology200
Completed
Not Applicable
Study of the improvement effect of proton pump inhibitors on symptoms in patients with reflux esophagitis (RE): a randomized comparative study of omeprazole 20mg vs. rabeprazole 10mg using the time (number of days) to improvement in symptoms as an indexpatients with reflux esophagitis
JPRN-UMIN000003078Japan Dyspepsia Society220
Completed
Not Applicable
Study of the improvement effect of proton pump inhibitors for gastric ulcers after endoscopic submucosal dissection (ESD): a randomized comparative study of omeprazole iv vs. esomeprazole pogastric cancer
JPRN-UMIN000010958Department of Gastroenterology, Ishikawa Prefectural Central Hospital200
Completed
Not Applicable
Study of the improvement effect of proton pump inhibitors on symptoms in patients with reflux esophagitis (RE): a randomized comparative study of omeprazole 20mg vs. rabeprazole 10mg using the time (number of days) to improvement in symptoms as an indexreflux esophagitis
JPRN-UMIN000002955Japan Dyspepsia Society220